Hansoh Pharmaceutical Group Company Limited (3692.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 193.8B |
| Enterprise Value | 190.49B |
| P/E Ratio | 27 |
| PEG Ratio | 0.75 |
| Price/Sales Ratio | 11.33 |
| Price/Book Ratio | 4.76 |
| Enterprise/Revenue | 11.3 |
| Enterprise/EBITDA | 28.4 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.42 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.18 |
Income Statement
| Revenue | 15.03B |
| Revenue/Share | 2.62 |
| Gross Profit | 13.51B |
| EBITDA | 5.79B |
| Net Income | 5.56B |
| Diluted EPS | 0.93 |
Balance Sheet
| Total Cash | 37.38B |
| Total Cash/Share | 6.17 |
| Total Debt | 4.23B |
| Total Debt/Equity | 0.11 |
| Current Ratio | 4.88 |
| Book Value Per Share | 6.23 |
Price History
| 52-Week Change | -4.85 |
| 52-Week High | 44.22 |
| 52-Week Low | 28.06 |
| Moving Average 50 Days | 33.73 |
| Moving Average 200 Days | 34.05 |
Statistics
| Average Volume | 10.93M |
| Shares Outstanding | 6.06B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.41 |
| Trailing Annual Dividend Yield | 1.39 |
| Payout Ratio | 0.3 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
